Bulletin 343 launched - Omega-3 fatty acid compounds and other fish oils

This bulletin provides information and resources to support deprescribing of these products which are considered low priority for prescribing and not cost-effective (with the exception of icosapent ethyl prescribed in line with NICE TA805).

Resources include data, audit, searches, patient information and an educational presentation.